Abstract:Ebola virus (EBOV) causes a hemorrhagic fever with fatality rates up to 90%. The EBOV entry process is complex and incompletely understood. Following attachment to host cells, EBOV is trafficked to late endosomes/lysosomes where its glycoprotein (GP) is processed to a 19-kDa form, which binds to the EBOV intracellular receptor Niemann-Pick type C1. We previously showed that the cathepsin protease inhibitor, E-64d, blocks infection by pseudovirus particles bearing 19-kDa GP, suggesting that further cathepsin action is needed to trigger fusion. This, however, has not been demonstrated directly. Since 19-kDa Ebola GP fusion occurs in late endosomes, we devised a system in which enriched late endosomes are used to prepare supported planar endosomal membranes (SPEMs), and fusion of fluorescent (pseudo)virus particles is monitored by total internal reflection fluorescence microscopy. We validated the system by demonstrating the pH dependencies of influenza virus hemagglutinin (HA)-mediated and Lassa virus (LASV) GP-mediated fusion. Using SPEMs, we showed that fusion mediated by 19-kDa Ebola GP is dependent on low pH, enhanced by Ca2+, and augmented by the addition of cathepsins. Subsequently, we found that E-64d inhibits full fusion, but not lipid mixing, mediated by 19-kDa GP, which we corroborated with the reversible cathepsin inhibitor VBY-825. Hence, we provide both gain- and loss-of-function evidence that further cathepsin action enhances the fusion activity of 19-kDa Ebola GP. In addition to providing new insights into how Ebola GP mediates fusion, the approach we developed employing SPEMs can now be broadly used for studies of virus and toxin entry through endosomes. IMPORTANCE Ebola virus is the causative agent of Ebola virus disease, which is severe and frequently lethal. EBOV gains entry into cells via late endosomes/lysosomes. The events immediately preceding fusion of the viral and endosomal membranes are incompletely understood. In this study, we report a novel in vitro system for studying virus fusion with endosomal membranes. We validated the system by demonstrating the low pH dependencies of influenza and Lassa virus fusion. Moreover, we show that further cathepsin B action enhances the fusion activity of the primed Ebola virus glycoprotein. Finally, this model endosomal membrane system should be useful in studying the mechanisms of bilayer breaching by other enveloped viruses, by non-enveloped viruses, and by acid-activated bacterial toxins.

Eukaryotic Expression and Purification of Ebola Virus Glycoprotein GP1 Subunit Fusion Protein

Design of Fusion Proteins for Efficient and Soluble Production of Immunogenic Ebola Virus Glycoprotein in Escherichia coli.

Production and Characterization of Monoclonal Antibodies Against Gp Protein of Ebola Virus

Prokaryotic Expression And Immunogenicity In Rabbit Of Ebola Virus Vp40 Matrix Protein

Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40

Construction and Evaluation of DNA Vaccine Encoding Ebola Virus Glycoprotein Fused with Lysosome-Associated Membrane Protein

The Induction and Characterization of Monoclonal Antibodies Specific to GP of Ebola Virus.

In Silico Analyses and Experimental Validation of the MHC Class-I Restricted Epitopes of Ebolavirus GP.

On Prokaryotic Expression,Identification of Expression Form,and Purification of Reticuloendotheliosis Virus Gp90 Protein

Screening of host proteins interacting with GP, VP30, NP,and L proteins of Ebola virus by yeast two-hybrid system

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development

Ebola Virus Glycoprotein Strongly Binds to Membranes in the Absence of Receptor Engagement

Expression and Immunogenicity of VP40 Protein of ZEBOV.

An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion

Dual monoclonal antibody-based sandwich ELISA for detection of in vitro packaged Ebola virus

A novel in vitro system of supported planar endosomal membranes (SPEMs) reveals an enhancing role for cathepsin B in the final stage of Ebola virus fusion and entry

Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity

Prokaryotic Expression and Antibody Preparation of Truncated Glycoprotein of Crimean-Congo Hem-Orrhagic Fever Virus

Research Progress on Ebola Virus Glycoprotein

Construction, Expression and Purification of HIV-1 P24-Gp41 Fusion Protein in E.coli

[Expression and Immunogenicity of Equine Infectious Anemia Virus Membrane Protein GP90].